NovaBridge Financial Statements From 2010 to 2025

NBP Stock   4.50  0.11  2.51%   
Analyzing historical trends in various income statement and balance sheet accounts from NovaBridge Biosciences' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting NovaBridge Biosciences' valuation are summarized below:
There are currently one hundred twenty fundamental ratios for NovaBridge Biosciences that can be evaluated and compared over time across peers in the industry. Investors and active traders are advised to check NovaBridge Biosciences' last-minute fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 12/24/2025, Market Cap is likely to drop to about 65.6 M. In addition to that, Enterprise Value is likely to drop to about 4.4 M

NovaBridge Biosciences Total Revenue

0.0

Check NovaBridge Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBridge Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 87.1 K or Selling General Administrative of 432.4 M, as well as many indicators such as Price To Sales Ratio of 153, Dividend Yield of 8.0E-4 or PTB Ratio of 0.36. NovaBridge financial statements analysis is a perfect complement when working with NovaBridge Biosciences Valuation or Volatility modules.
  
Build AI portfolio with NovaBridge Stock
Check out the analysis of NovaBridge Biosciences Correlation against competitors.
To learn how to invest in NovaBridge Stock, please use our How to Invest in NovaBridge Biosciences guide.

NovaBridge Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets202 M212.7 MB
Slightly volatile
Short and Long Term Debt Total3.7 M3.9 M143.1 M
Slightly volatile
Other Current Liabilities7.2 M7.5 M227.8 M
Slightly volatile
Total Current LiabilitiesM8.5 M299 M
Pretty Stable
Property Plant And Equipment Net3.6 M3.8 M36.8 M
Pretty Stable
Current Deferred Revenue100.7 K106 K10 M
Slightly volatile
Cash64.8 M68.3 M1.2 B
Slightly volatile
Non Current Assets Total34.2 M36 M376.1 M
Very volatile
Cash And Short Term Investments164.7 M173.4 M943 M
Slightly volatile
Net Receivables1.1 M1.2 M10.2 M
Slightly volatile
Common Stock Shares Outstanding77.8 M81.2 M65.7 M
Slightly volatile
Short Term Investments170 M105.1 M233.3 M
Pretty Stable
Liabilities And Stockholders Equity202 M212.7 MB
Slightly volatile
Non Current Liabilities Total2.9 M3.1 MB
Slightly volatile
Other Current AssetsM2.1 M641.2 M
Pretty Stable
Other Stockholder Equity1.4 B1.5 BB
Slightly volatile
Total Liabilities10.9 M11.5 M1.3 B
Slightly volatile
Total Current Assets167.9 M176.7 M1.6 B
Slightly volatile
Intangible Assets14.2 M15 M118.3 M
Slightly volatile
Common Stock18.1 K19 K30.5 K
Slightly volatile
Non Currrent Assets Other1.3 M1.4 M29.9 M
Pretty Stable
Capital Lease Obligations6.7 M3.9 M14.6 M
Slightly volatile
Net Invested Capital316.7 M201.2 M610.6 M
Slightly volatile
Property Plant And Equipment Gross3.8 MM26.4 M
Slightly volatile
Capital Stock15.4 K17.1 K19.2 K
Slightly volatile
Net Working Capital301.6 M168.2 M561.5 M
Slightly volatile
Short and Long Term Debt3.8 M4.9 MM
Slightly volatile
Long Term Debt6.6 M7.5 M8.2 M
Slightly volatile

NovaBridge Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.8 M1.9 MM
Slightly volatile
Selling General Administrative432.4 M216.5 M234.7 M
Slightly volatile
Other Operating Expenses707.4 M375.4 M622.2 M
Slightly volatile
Research Development313.7 M158.9 M332.5 M
Very volatile
Total Operating Expenses702.8 M375.4 M619 M
Slightly volatile
Net Interest Income6.9 M7.5 M4.3 M
Slightly volatile
Interest Income6.9 M7.5 M4.3 M
Slightly volatile
Reconciled Depreciation1.8 M978 K4.3 M
Slightly volatile

NovaBridge Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow286.9 M302 M820.9 M
Slightly volatile
Other Cashflows From Financing Activities348.7 K367.1 K644 M
Pretty Stable
Depreciation929.1 K978 K10 M
Slightly volatile
Capital Expenditures45.6 K48 K17.1 M
Slightly volatile
End Period Cash Flow64.8 M68.2 M1.1 B
Slightly volatile
Dividends Paid4.2 M4.8 M5.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield8.0E-49.0E-40.001
Slightly volatile
Capex To Depreciation0.04660.04916.5395
Slightly volatile
Cash Per Share2.032.135820.5772
Slightly volatile
Income Quality0.741.05980.7491
Slightly volatile
Intangibles To Total Assets0.0070.00730.1828
Slightly volatile
Current Ratio21.9520.90056.7193
Slightly volatile
Capex Per Share6.0E-46.0E-40.2702
Slightly volatile
Average Receivables54.5 M37.8 M59.5 M
Slightly volatile
Interest Debt Per Share0.04540.04782.3815
Slightly volatile
Debt To Assets0.01730.01830.1199
Slightly volatile
Graham Number39.3544.2748.2683
Slightly volatile
Ebt Per Ebit1.370.96641.4057
Slightly volatile
Quick Ratio21.9520.90056.767
Slightly volatile
Net Income Per E B T0.420.44731.03
Very volatile
Cash Ratio8.488.07463.7299
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.00091.0561
Slightly volatile
Debt Ratio0.01730.01830.1199
Slightly volatile
Gross Profit Margin21.9820.935.9436
Slightly volatile

NovaBridge Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap65.6 M69 MB
Very volatile

NovaBridge Fundamental Market Drivers

About NovaBridge Biosciences Financial Statements

NovaBridge Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although NovaBridge Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in NovaBridge Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on NovaBridge Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue106 K100.7 K
Stock Based Compensation To Revenue 2.63  2.76 
Sales General And Administrative To Revenue 16.38  17.20 
Research And Ddevelopement To Revenue 29.32  30.78 
Capex To Revenue 0.04  0.04 
Revenue Per Share 0.06  0.06 
Ebit Per Revenue(131.04)(124.49)

Pair Trading with NovaBridge Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NovaBridge Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBridge Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against NovaBridge Stock

  0.45ALRS Alerus Financial CorpPairCorr
  0.44AAPL Apple IncPairCorr
  0.43CIZ Cizzle BiotechnologyPairCorr
  0.41ACW Actinogen MedicalPairCorr
  0.38MTC MMTEC Inc Tech BoostPairCorr
The ability to find closely correlated positions to NovaBridge Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NovaBridge Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NovaBridge Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NovaBridge Biosciences to buy it.
The correlation of NovaBridge Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NovaBridge Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NovaBridge Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NovaBridge Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for NovaBridge Stock Analysis

When running NovaBridge Biosciences' price analysis, check to measure NovaBridge Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBridge Biosciences is operating at the current time. Most of NovaBridge Biosciences' value examination focuses on studying past and present price action to predict the probability of NovaBridge Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBridge Biosciences' price. Additionally, you may evaluate how the addition of NovaBridge Biosciences to your portfolios can decrease your overall portfolio volatility.